Stay updated on BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial
Sign up to get notified when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.

Latest updates to the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNo significant changes detected; core study details and endpoints appear unchanged.SummaryDifference0.3%

- Check16 days agoChange DetectedNew content adds Paratus Clinical Research Woden and an updated data-sharing scope for Boehringer Ingelheim studies; older, more specific IPD sharing details and access criteria from 2022-era text have been removed.SummaryDifference8%

- Check30 days agoChange DetectedAdded a government-operation status notice and link details plus a version bump to v3.2.0; removed the previous v3.1.0 reference.SummaryDifference2%

- Check37 days agoChange Detected- Updated version to v3.1.0 and added the term Palmoplantar pustulosis; removed several older or broader drug-safety/quality terms (e.g., Drug Safety, Counterfeit Drugs, Substandard Drugs, Pharmaceutical Preparations, Pustulosis palmaris et plantaris).SummaryDifference0.4%

- Check52 days agoChange DetectedNew revision label v3.0.2 replaces v3.0.1. The 'Back to Top' link was removed—minor UI change with no impact on core content.SummaryDifference0.1%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%

Stay in the know with updates to BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.